MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: KleidungDarkweb mixerAntwortenAntworten: Darkweb mixer <blockquote><div class="quotetitle">Zitat von Gast am 24. März 2026, 14:22 Uhr</div>[url=https://www.facebook.com/public/Zoya-Demidenko/ ]Zoya Demidenko[/url]: Researcher in Tumor Biology [url=https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/ ]Zoya Demidenko[/url] is a recognized scholar associated with the Unit of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Before that, she worked at the NIH and New York Medical College, developing a solid base in clinical investigation. Demidenko's scholarly output encompasses a number of critical areas, including the PI3K/AKT/mTOR signaling pathway, cellular cycle management, biological aging, and malignancy biology. Currently, she has written over 46 academic publications, which have accumulated more than 4,100 mentions — a indicator to the significance of her research. Among her most notable discoveries lies in understanding the processes of cell aging. Her research demonstrated that when the cell cycle is arrested yet cellular expansion proceeds, the cells undergo senescence. Importantly, [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord ]Zoya Demidenko[/url] demonstrated that this process is inhibited by medication using agents such as rapamycin. [url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey= ]Zoya Demidenko[/url] has also added considerably to cancer treatment investigation, particularly in the area of cyclotherapy — a approach designed to safeguarding normal tissue from chemotherapy whilst leaving malignant cells susceptible. This approach offers major promise for reducing the toxic effects of oncological therapy. Throughout her scientific life, Demidenko has partnered with top researchers internationally, including Dr. Mikhail Blagosklonny. Her research appears in prestigious publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Holding an h-index of 33, [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012 ]Zoya Demidenko[/url] ranks as a influential voice in contemporary cancer science, whose results continue to influence our knowledge of the way cells grow old, resist therapy, and how cancer can be more effectively combated. https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord </blockquote><br> Abbrechen
